Hossein Ardehali

Dr. Hossein Ardehali MD, PhD

Associate Professor, Northwestern University, Feinberg School of Medicine


          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

GLG News by Dr. Hossein Ardehali MD, PhD, Associate Professor

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

New studies suggest DES may improve outcome in the setting of AMI

September 19, 2006

NEJM Articles on DES in MI | content.nejm.org

The studies reported in the recent issues of NEJM are significant in that they provide evidence that DES in the setting of AMI with ST elevation may improve outcome. Taxel-eluting stents showed nonsignificant improvement in adverse cardiac events, but sirolimus-eluting stents showed a significant reduction in target vessel revascularization

 

Generic clopidogrel should not alter its use

August 18, 2006

Mixed thoughts on how generic clopidogrel might impact patients, providers | www.theheart.org

There are clear indications to use clopidogrel

Clopidogrel should not be used in every patient with coronary artery disease

Page : 11 to 2 of 2

Subscribe to Updates

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines

Leading institutions connect with Hossein Ardehali through GLG